Dermatology News

Mothers who exclusively breastfed for longer than 3 months significantly lowered their child’s risk of eczema, according to findings presented at the American Academy of Allergy, Asthma and Immunology Annual Meeting.

SCOTTSDALE, Ariz. — Due to the diversity of its expression, psoriatic arthritis is not often able to take full advantage of treatments for similar inflammatory arthritides or psoriasis, according to a presentation here.

The incidence of invasive group B Streptococcus rose among nonpregnant adults between 2008 and 2016, particularly among those with obesity and diabetes, according to a study published in JAMA Internal Medicine.

A 12-year-old healthy female athlete presented to the dermatology clinic for a mole check. The patient was most concerned about a new black spot on her left heel. She noticed it 2 weeks earlier. It did not resolve with rubbing alcohol. It was asymptomatic and had not changed in size or color since she noticed it. There was no pain, and she continued to attend field hockey practice multiple times per week without any issues.

The two compendia that Medicare Part D recognizes to make coverage determinations for off-label prescribing were “incomplete, outdated, idiosyncratic, and unpredictable” for some chronic dermatologic conditions, according to findings recently published in JAMA Dermatology.

LAS VEGAS — New-onset psoriasis occurred more frequently in children with inflammatory bowel disease who received anti-TNF biologic therapy than it did in their counterparts who did not receive biologics, according to a presenter at the Crohn’s & Colitis Congress.

Although methotrexate is generally well-tolerated and efficacious in the treatment of psoriasis, it is even more effective, with fewer reported adverse effects, among patients with psoriasis but without psoriatic arthritis, compared with those with both, according data published in JAMA Dermatology.

Inflammatory bowel disease events, including Crohn’s disease and ulcerative colitis, are uncommon in patients with psoriatic arthritis, psoriasis and ankylosing spondylitis who were treated with secukinumab, according to data published in the Annals of the Rheumatic Diseases.

A “statistically significant” proportion of adult patients using Olumiant for moderate to severe atopic dermatitis had clearer skin vs. those using placebo in two phase 3 studies evaluating its efficacy and safety, according to a press release from Eli Lilly and Co.

Argentum Medical announced that it has been awarded a 3-year, $8.4 million contract with the Biomedical Advanced Research and Developmental Authority, or BARDA, to repurpose its commercial Silverlon technology for skin injuries occurring during radiological and nuclear emergencies.